JPH04371161A - Web of chitin - Google Patents
Web of chitinInfo
- Publication number
- JPH04371161A JPH04371161A JP3176247A JP17624791A JPH04371161A JP H04371161 A JPH04371161 A JP H04371161A JP 3176247 A JP3176247 A JP 3176247A JP 17624791 A JP17624791 A JP 17624791A JP H04371161 A JPH04371161 A JP H04371161A
- Authority
- JP
- Japan
- Prior art keywords
- chitin
- fibers
- web
- wound
- fibrils
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002101 Chitin Polymers 0.000 title claims abstract description 50
- 239000000835 fiber Substances 0.000 claims abstract description 46
- 208000027418 Wounds and injury Diseases 0.000 abstract description 44
- 206010052428 Wound Diseases 0.000 abstract description 42
- 239000000463 material Substances 0.000 abstract description 29
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 4
- 239000000853 adhesive Substances 0.000 abstract description 2
- 230000001070 adhesive effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 229920001661 Chitosan Polymers 0.000 description 12
- 210000000416 exudates and transudate Anatomy 0.000 description 10
- 238000005469 granulation Methods 0.000 description 10
- 230000003179 granulation Effects 0.000 description 10
- -1 poly(N-acetyl-D-glucosamine) Polymers 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 8
- 208000004210 Pressure Ulcer Diseases 0.000 description 6
- 230000006196 deacetylation Effects 0.000 description 6
- 238000003381 deacetylation reaction Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000005230 Leg Ulcer Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000037305 epidermis formation Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920000153 Povidone-iodine Polymers 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000001112 coagulating effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229960001621 povidone-iodine Drugs 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 208000025962 Crush injury Diseases 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は,キチンからなるウェブ
状物に関するものである。特に,医療分野における深い
創傷,例えば,挫滅傷,褥瘡,下腿潰瘍等の治療の為の
創傷治療材として好適なキチンウェブ状物に関するもの
である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a web-like material made of chitin. In particular, the present invention relates to a chitin web material suitable as a wound treatment material for treating deep wounds in the medical field, such as crush wounds, bedsores, and leg ulcers.
【0002】0002
【従来の技術】アミノ多糖類であるキチンは,セルロー
スに類似した化学構造を有しているにかかわらず,セル
ロースとは異なった興味ある多くの特徴を有している。
例えば金属,タンパク質等に対し良好な吸着性がある。
又生体の創傷に使用すると,治癒を促進する効果も認め
られている。このような効果を有効に引き出す形として
,従来から繊維やフィブリルの形が提案さており,その
不織布としての利用は,例えば特開昭61−24096
3号公報に記載のものがある。しかし,これらは特定の
目的に対しては有効であるが,他の目的にたいしては必
ずしも十分なものではない。例えば創傷の治療に対して
も問題があった。BACKGROUND OF THE INVENTION Although chitin, an aminopolysaccharide, has a chemical structure similar to cellulose, it has many interesting characteristics that are different from cellulose. For example, it has good adsorption properties for metals, proteins, etc. It has also been shown to have the effect of promoting healing when used on wounds in living organisms. Fiber and fibril shapes have long been proposed as shapes that can effectively bring out such effects, and their use as nonwoven fabrics has been proposed, for example, in Japanese Patent Application Laid-Open No. 61-24096.
There is one described in Publication No. 3. However, while these are effective for certain purposes, they are not necessarily sufficient for other purposes. For example, there were also problems with wound treatment.
【0003】一般的な創傷治療の技術は,近年進歩が著
しく,熱傷や外傷,植皮片をとった後の採皮創等の比較
的浅い傷に対しての治療が進んでおり,これらを治療す
る創傷被覆保護材として多くの商品が使用されている。
これらの主な分類としては,合成高分子からなる合成材
料と天然高分子からなる生体材料とに分類することがで
きる。合成材料には,ポリウレタンフイルム(商品名:
オプサイト,バイオクルーシブ),ポリウレタンスポン
ジ(商品名:デユオアクテイブ),ポリペプチドをコー
テイングしたナイロンフイブリツク(商品名:バイオブ
レン)等があり,生体材料としては,凍結乾燥豚皮(商
品名:アロアスク),コラーゲン繊維シート(商品名:
メイパツク),キチン繊維シート(商品名:ベスキチン
W)等がある。[0003] General wound treatment techniques have made remarkable progress in recent years, and progress has been made in treating relatively shallow wounds such as burns, trauma, and skin harvest wounds after skin grafts have been removed. Many products are used as wound dressings. These materials can be mainly classified into synthetic materials made of synthetic polymers and biomaterials made of natural polymers. The synthetic material is polyurethane film (product name:
Biomaterials include lyophilized pork skin (trade name: Opsite, Bioclusive), polyurethane sponge (trade name: Duoactive), nylon fiber coated with polypeptide (trade name: BioBrene), etc. : Aroask), collagen fiber sheet (product name:
May Pack), chitin fiber sheet (trade name: Veschitin W), etc.
【0004】これらは,いずれも浅い傷を治療するもの
であるが,深い創傷,例えば,挫滅傷,褥瘡,下腿潰瘍
等の場合は,皮膚は勿論のこと,肉芽も大幅な欠損を起
こすので,深い立体的な傷となり,滲出液が多く,感染
も起こりやすいので,上記のような創傷被覆保護材では
治療しにくいのが実情である。例えば,合成材料のもの
を使用すると,これらには創からの滲出液を除去する作
用がないので,滲出液が患部に貯留し,治癒がますます
遅れることになる。また,生体材料の場合は,滲出液の
除去は比較的十分であるが,いずれも厚みの薄いシート
状であるので,立体的な創面に十分密着しなかったり,
滲出液によって融解することが多く,十分な保護効果を
期待できないのが実情である。従って,これら深い傷に
対する現在の治療法としては,局方のガーゼに抗菌剤を
含んだ軟膏を塗布したものや,ヨードを含んだポリビニ
ルピロリドン液を塗布したもので保護する等のように,
滲出液の除去と殺菌のみを目的とした治療が行われてい
る。[0004] All of these methods treat shallow wounds, but in the case of deep wounds such as crush wounds, bedsores, leg ulcers, etc., not only the skin but also the granulation tissue will be severely damaged. The reality is that it is difficult to treat with the above-mentioned wound dressings because it results in a deep three-dimensional wound, has a lot of exudate, and is prone to infection. For example, synthetic materials do not remove exudate from the wound, causing it to pool in the wound, further delaying healing. In addition, in the case of biomaterials, removal of exudate is relatively sufficient, but since they are in the form of thin sheets, they may not adhere well to the three-dimensional wound surface.
The reality is that it often melts due to exudate and cannot be expected to provide sufficient protection. Therefore, the current treatments for these deep wounds include protecting them with pharmacopoeial gauze coated with ointment containing an antibacterial agent or polyvinylpyrrolidone solution containing iodine.
Treatment is aimed solely at removal of exudate and disinfection.
【0005】[0005]
【発明が解決しようとする課題】このような治療では,
早い時期の肉芽生成や表皮形成は期待できるものではな
い。創傷治療の目的は,創部をできるだけ早く治癒状態
にもっていくことである。そのためには,創傷被覆保護
材としての役割は,創面に十分に密着して保護でき,滲
出液を十分に吸収するとともに創外に排除することがで
き,肉芽生成や表皮形成を促進することができ,また,
治療途中に容易に交換できるものであることが好ましい
。[Problem to be solved by the invention] In this kind of treatment,
Early granulation and epidermal formation cannot be expected. The goal of wound treatment is to bring the wound to a state of healing as quickly as possible. To this end, the role of a wound covering material is to be able to adhere to and protect the wound surface sufficiently, to absorb exudate sufficiently and to expel it outside the wound, and to promote granulation and epidermis formation. Can, also,
It is preferable that it be easily replaceable during treatment.
【0006】すでに販売されているキチン不織布からな
るシートである「ベスキチンW」(ユニチカ社製)は,
多くの創傷の保護に好ましく使用され,好評である。特
に肉芽生成や表皮形成が良好であることを特徴とする。
しかし,この材料も,深い傷に対しては使用上必ずしも
好ましいものとはいえない。[0006] "Beskitin W" (manufactured by Unitika), a sheet made of chitin nonwoven fabric, is already on the market.
It is preferably used to protect many wounds and is well received. It is particularly characterized by good granulation and epidermis formation. However, this material is not necessarily suitable for use against deep scratches.
【0007】このような現状の中で,本発明は,深くて
広い創傷の治療の為の創傷被覆保護材として好適なキチ
ンウェブ状物を提供することを目的としている。Under these circumstances, an object of the present invention is to provide a chitin web-like material suitable as a wound covering material for treating deep and wide wounds.
【0008】[0008]
【課題を解決するための手段】本発明者は,上記の目的
を達成するため鋭意研究を重ねた結果,キチンの繊維又
はフィブリルからなるキチンウェブ状物がかかる課題を
解決できることを見出し,本発明に到達したものである
。[Means for Solving the Problems] As a result of intensive research to achieve the above object, the present inventor found that a chitin web-like material made of chitin fibers or fibrils can solve the problems, and the present invention has been made. has been reached.
【0009】すなわち,本発明は,キチンの繊維又はフ
ィブリルからなるキチンウェブ状物を要旨とするもので
ある。That is, the gist of the present invention is a chitin web-like material made of chitin fibers or fibrils.
【0010】以下,本発明を詳細に説明する。キチンと
は,甲殻類,昆虫類等の外骨格を塩酸処理並びに苛性ソ
ーダ処理して灰分および蛋白物質を除去して得られるポ
リ(N−アセチル−D−グルコサミン)またはこのポリ
(N−アセチル−D−グルコサミン)を濃アルカリで処
理して得られる脱アセチル化物(脱アセチル化度で数%
から100%までの値のものがある)であり,これらの
うち,脱アセチル化度が高く,酸に溶解するものを特に
キトサンと呼んでいる。The present invention will be explained in detail below. Chitin is poly(N-acetyl-D-glucosamine) obtained by treating the exoskeleton of crustaceans, insects, etc. with hydrochloric acid and caustic soda to remove ash and protein substances, or this poly(N-acetyl-D-glucosamine). - Deacetylated product obtained by treating glucosamine) with concentrated alkali (several % deacetylation degree)
Among them, chitosan has a high degree of deacetylation and is soluble in acids, and is particularly called chitosan.
【0011】本発明で用いられるキチンは,このような
キチン,脱アセチル化キチン,あるいはキトサンであり
,さらには,キチンあるいはキトサンのグルコサミン残
基の−OH基又は−CH2 OH基又はアミノ基がエス
テル化,エーテル化,カルボキシメチル化,ヒドロキシ
エチル化あるいはO−エチル化された等のキチン誘導体
も含まれる。[0011] The chitin used in the present invention is such chitin, deacetylated chitin, or chitosan, and furthermore, the -OH group, -CH2 OH group, or amino group of the glucosamine residue of chitin or chitosan is an ester. It also includes chitin derivatives which have been oxidized, etherified, carboxymethylated, hydroxyethylated or O-ethylated.
【0012】キチンの繊維又はフィブリルとは,これら
キチンを溶剤に溶かして溶液とし,繊維又はフィブリル
としたものを意味する。キチンの溶液を作るには,基本
的には2つの方法がある。その1つは,脱アセチル化度
の低いキチンの場合であり,これらの溶媒としては,ジ
メチルアセトアミド又はN−メチルピロリドンと塩化リ
チウムとの混合液,トリクロル酢酸とハロゲン化炭化水
素との混合液等がある。キチンは,粉末の形でこれらの
溶媒に2〜10重量%程度溶解させると,粘調で透明な
溶液を作ることができる。これらから繊維を作るには,
例えば,加圧タンクからギヤーポンプ等で計量送液し,
フイルターを含んだノズル,例えば,0.07mmφ程
度の微細な孔から,凝固液である水又はアルコール等の
液中に押出し,凝固した後,定速で引取る方法がある。
できた繊維は,十分に溶剤,凝固液等の不純物を除去す
る。本発明に使用する場合の個々の繊維の太さは,0.
2〜50デニール程度で,好ましくは0.5〜10デニ
ールである。[0012] Chitin fibers or fibrils refer to fibers or fibrils obtained by dissolving chitin in a solvent to form a solution. There are basically two ways to make a chitin solution. One is the case of chitin with a low degree of deacetylation, and these solvents include dimethylacetamide or a mixture of N-methylpyrrolidone and lithium chloride, a mixture of trichloroacetic acid and halogenated hydrocarbons, etc. There is. When chitin is dissolved in powder form in these solvents at a concentration of about 2 to 10% by weight, a viscous and transparent solution can be produced. To make fibers from these,
For example, by pumping a measured amount of liquid from a pressurized tank using a gear pump, etc.
There is a method in which the material is extruded into a coagulating liquid such as water or alcohol through a nozzle containing a filter, for example, a fine hole of about 0.07 mmφ, and after solidifying, it is withdrawn at a constant speed. The resulting fibers are thoroughly cleaned of impurities such as solvent and coagulation liquid. The thickness of each fiber when used in the present invention is 0.
It is about 2 to 50 deniers, preferably 0.5 to 10 deniers.
【0013】フィブリルについては,溶液をかき混ぜな
がら凝固液中に導入したり,キチン溶液に水溶性物質,
例えば,ポリグリセリン等を混入した後に溶液をよく混
合し,熱水で水溶性物質を除去する方法等によって得る
ことができる。Regarding fibrils, it is possible to introduce them into the coagulation solution while stirring the solution, or to add a water-soluble substance or a water-soluble substance to the chitin solution.
For example, it can be obtained by mixing polyglycerin or the like, thoroughly mixing the solution, and removing water-soluble substances with hot water.
【0014】ここで,繊維とは長手方向に断面形状が均
一なものを意味し,かつエンドレスに作成されたもので
あり,一方フィブリルとは,長手方向の断面形状が不均
一でかつ長さの比較的短いものを意味する。[0014] Here, fiber means something with a uniform cross-sectional shape in the longitudinal direction and is created endlessly, whereas fibril means something with a non-uniform cross-sectional shape in the longitudinal direction and a long length. means relatively short.
【0015】脱アセチル化キチンの繊維又はフィブリル
は,これらのキチンの繊維又はフィブリルと濃い苛性ソ
ーダ水溶液,例えば,10〜30重量%の濃度,80℃
以上の温度で処理することによって作成することができ
る。脱アセチル化度の調整は,苛性ソーダの濃度,温度
,処理時間を調整することによって行うことができる。Deacetylated chitin fibers or fibrils are prepared by adding these chitin fibers or fibrils to a concentrated aqueous solution of caustic soda, for example at a concentration of 10 to 30% by weight, at 80°C.
It can be created by processing at a temperature above. The degree of deacetylation can be adjusted by adjusting the concentration of caustic soda, temperature, and treatment time.
【0016】脱アセチル化度の高いキチン,例えば,キ
トサンから繊維又はフィブリルを作るには,溶剤として
は,例えば,酢酸の水溶液を使用することができる。例
えば,酢酸を0.1〜5重量%程度含む水溶液にキトサ
ン0.5〜10重量%を溶解させると,透明で粘調な溶
液ができる。To make fibers or fibrils from chitin with a high degree of deacetylation, such as chitosan, an aqueous solution of acetic acid, for example, can be used as the solvent. For example, when 0.5 to 10% by weight of chitosan is dissolved in an aqueous solution containing about 0.1 to 5% by weight of acetic acid, a transparent and viscous solution is produced.
【0017】これをキチン溶液の場合と同じように加圧
タンクに入れ,ギヤーポンプで計量し,微細なノズルか
ら吐出させる。凝固液としては,単なる水,アルコール
又はアルカリ水溶液,アルカリを含んだアルコール液等
を使用することができる。凝固した繊維を定速で引取り
,さらに,十分に洗浄して溶剤,凝固液等の不純物を除
去すると,キトサン繊維を得ることができる。本発明に
使用する際の個々の繊維又はフィブリルの太さは,やは
り0.2〜50デニール程度で,好ましくは0.5〜1
0デニールである。これらの繊維又はフィブリルは,そ
のまま使用してもよいが,無水酢酸を含んだアルコール
中で処理して,若干のアミノ基のアセチル化を進めても
よい。[0017] As in the case of the chitin solution, this is placed in a pressurized tank, measured using a gear pump, and discharged from a fine nozzle. As the coagulating liquid, simple water, alcohol or alkaline aqueous solution, alcoholic liquid containing alkali, etc. can be used. Chitosan fibers can be obtained by taking the coagulated fibers at a constant speed and thoroughly washing them to remove impurities such as the solvent and coagulating liquid. The thickness of each fiber or fibril used in the present invention is also about 0.2 to 50 deniers, preferably 0.5 to 1 denier.
It is 0 denier. These fibers or fibrils may be used as they are, or may be treated in alcohol containing acetic anhydride to advance acetylation of some amino groups.
【0018】これらキチンの繊維又はフィブリルからな
るキチンウェブ状物とは,これらの繊維又はフィブリル
の綿状集合体のことを意味する。この製造方法は,まず
,キチン繊維を短繊維,例えば,1mm〜5cm程度の
長さに切断し,繊維又はフィブリルの1本ずつを開繊す
ることによって行うことができる。開繊は,例えば,フ
トン綿を作るカード機等によって多数本の集束物である
キチン繊維を1本ずつ開繊すると,ウェブ状物を作るこ
とができる。この際,ウェブ状物のからみをよくするた
めに,事前に繊維にクリンプをかけてもよい。[0018] The chitin web consisting of these chitin fibers or fibrils means a flocculent aggregate of these fibers or fibrils. This manufacturing method can be carried out by first cutting chitin fibers into short fibers, for example, lengths of about 1 mm to 5 cm, and opening each fiber or fibril one by one. For example, by opening a large number of bundled chitin fibers one by one using a card machine that produces futon cotton, a web-like product can be created. At this time, the fibers may be crimped in advance to improve the entanglement of the web-like material.
【0019】でき上がったウェブ状物は,そのまま使用
してもよいし,上部から若干圧迫してマツト状にしても
よいし,また,接着剤で繊維間を軽く接着させてもよい
。これらウェブ状物を例えば創傷被覆保護材として使用
するためには,これらを小分けして滅菌袋に詰め,滅菌
した後に使用することができる。なお,これらウェブ状
物に抗生物質,殺菌剤,創傷治療剤等の薬剤を付与して
使用することもできる。The completed web-like material may be used as it is, or may be slightly pressed from above to form a mat-like material, or the fibers may be lightly adhered with an adhesive. In order to use these web-like materials, for example, as wound dressings, they can be divided into portions, packed into sterile bags, and used after sterilization. Note that these web-like materials can also be used by applying drugs such as antibiotics, bactericidal agents, and wound treatment agents.
【0020】このようにして得られた本発明のウェブ状
物は,挫滅傷,褥瘡,下腿潰瘍等の深い傷の治療に使用
すると,滲出液の排除効果に優れ,密着性がよく,肉芽
生成,表皮形成に優れているので,良好な治療効果をあ
げることができるものである。[0020] When the web-like material of the present invention thus obtained is used to treat deep wounds such as crush wounds, bedsores, and leg ulcers, it has an excellent effect of eliminating exudate, has good adhesion, and inhibits granulation formation. Since it is excellent in epidermal formation, it can produce good therapeutic effects.
【0021】[0021]
【実施例】以下,本発明を実施例によってさらに具体的
に説明する。
実施例1
粗キチン粉末(新日本化学製)を1N−塩酸にて40℃
,1時間処理し,さらに,3%苛性ソーダ水溶液中で9
0℃,3時間加熱処理し,粗キチン粉末中に含まれてい
るカルシウム分及び蛋白質を除去した。このキチン粉末
をジメチルアセトアミドと塩化リチウムとの混合溶媒(
重量比92:8)に6重量%溶解し,透明の溶液を作成
した。この溶液を1480メツシユのステンレスネツト
で濾過した後,タンクに詰め,圧縮空気で加圧しながら
ギヤーポンプにて送液し,0.05mmφのノズルから
80℃の熱水中に押出し,凝固した後,10m/min
の速度で引取り,再度熱水で十分に洗浄すると,単糸
デニール0.8デニールのキチン繊維を得ることができ
た。これを乾燥した後,1cmの長さに切断し,開繊カ
ード機でキチン繊維のウェブ状物を作成した。このウェ
ブ状物を滅菌袋に詰め,滅菌した後,褥瘡の治療用とし
て使用した。EXAMPLES The present invention will now be explained in more detail by way of examples. Example 1 Crude chitin powder (manufactured by Shin Nippon Chemical) was heated at 40°C in 1N hydrochloric acid.
, treated for 1 hour, and further treated in a 3% caustic soda aqueous solution for 9 hours.
Heat treatment was performed at 0°C for 3 hours to remove calcium and protein contained in the crude chitin powder. This chitin powder was mixed with a mixed solvent of dimethylacetamide and lithium chloride (
A transparent solution was prepared by dissolving 6% by weight in a weight ratio of 92:8). After filtering this solution through a 1480 mesh stainless steel net, it is packed in a tank, pumped with a gear pump while pressurized with compressed air, extruded through a 0.05 mmφ nozzle into hot water at 80°C, and after solidifying, the solution is heated for 10 m /min
When the fibers were taken up at a speed of 1 and washed thoroughly with hot water again, chitin fibers with a single filament denier of 0.8 denier were obtained. After drying this, it was cut into lengths of 1 cm, and a web-like material of chitin fibers was created using a fiber opening card machine. This web-like material was packed into a sterile bag, sterilized, and then used to treat pressure ulcers.
【0022】患者は78才の女性で,脳障害のため半身
不随となり,寝たきりのため仙骨部に褥瘡を受傷した。
受傷後しばらくポビドンヨード溶液にて治療していたが
,結果は思わしくなく,本実施例のウェブ状物で治療し
た。治療開始時の傷の面積は6cm×10cmの楕円形
で,深さは筋肉部に達していた。治療法は,まず,患部
をオキシウルで浸した局方ガーゼで十分に洗浄,滅菌し
た後,キチン綿を創面に軽く圧迫充填した。その上から
ガーゼをあて,粘着テープで固定した。交換は2日おき
に行い,処置方法は最初のときと同じであった。The patient was a 78-year-old woman who became partially paralyzed due to a brain injury and suffered a pressure sore on her sacrum due to being bedridden. The patient was treated with a povidone-iodine solution for a while after the injury, but the results were not satisfactory, so the patient was treated with the web-like material of this example. At the start of treatment, the wound area was 6 cm x 10 cm oval, and its depth reached the muscle. The treatment involved first thoroughly cleaning and sterilizing the affected area with local gauze soaked in Oxyur, and then lightly compressing and filling the wound surface with chitin cotton. A piece of gauze was placed over it and fixed with adhesive tape. Exchanges were performed every 2 days, and the treatment method was the same as the first time.
【0023】その結果,6日目頃から良質な肉芽の生成
がみられ,日数の経過とともに肉芽生成が良好となり,
傷の大きさも縮小してきた。そして,最終的に45日間
で完全に傷がふさがり,完治した。[0023] As a result, formation of high-quality granulation was observed from around the 6th day, and as the days passed, granulation formation became better.
The size of the wound has also decreased. Finally, within 45 days, the wound completely closed and he was completely healed.
【0024】実施例2
実施例1で得られたキチン繊維を20重量%苛性ソーダ
液中で90℃で2時間処理した。十分に水洗後,この繊
維の脱アセチル化度を測定すると,55%であった。こ
の繊維を15mmに切断し,やはり開繊カード機でウェ
ブ状物を作成した後に滅菌した。Example 2 The chitin fibers obtained in Example 1 were treated in a 20% by weight caustic soda solution at 90° C. for 2 hours. After thorough washing with water, the degree of deacetylation of this fiber was measured and found to be 55%. This fiber was cut into 15 mm pieces, and a web-like product was also created using an opening card machine and then sterilized.
【0025】このウェブ状物は,オートバイ事故で受傷
した19才の男性の挫滅傷の治療に使用した。受傷部は
左足のかかとで,局所的に傷部は深く,骨および腱が露
出した状態であった。直後からデユオダーム(日本スク
イブ製)で治療したが,まったく良化する傾向になく,
本実施例のウェブ状物にかえた。治療は,患部を生食お
よびポビドンヨード液で十分に洗浄した後,キチンウェ
ブ状物で傷面を軽く圧迫充填し,その上にガーゼをあて
,粘着テープで固定した。さらに,まわりを包帯で保護
した。キチンウェブ状物の交換は,5日毎に行った。
交換時にはガーゼ側に多量の滲出液の付着がみられた。[0025] This web-like material was used to treat a crush injury of a 19-year-old man who had been injured in a motorcycle accident. The injured area was the heel of the left foot, and the wound was locally deep, exposing the bone and tendon. Immediately after treatment, she was treated with DuoDerm (manufactured by Nippon Squibb), but there was no tendency to improve at all.
The web-like material of this example was used instead. Treatment consisted of thoroughly cleaning the affected area with saline and povidone-iodine solution, then filling the wound surface with a chitin web-like material under pressure, placing gauze over it, and fixing it with adhesive tape. Furthermore, the surrounding area was protected with a bandage. The chitin web was replaced every 5 days. At the time of replacement, a large amount of exudate was observed on the gauze side.
【0026】最初の5日目には,すでに露出した骨や腱
の部分にまで良好な肉芽が生成しており,治療を続けた
ところ,10日目,15日目ではさらに良好となり,2
5日目には,肉芽生成および表皮形成が完了し,患部は
完治した。なお,交換時には,キチンウェブ状物の除去
は非常に容易であった。[0026] On the first 5 days, good granulation was already formed even in the exposed bones and tendons, and as the treatment was continued, it became even better on the 10th and 15th days.
On the 5th day, granulation and epidermis formation were completed, and the affected area was completely healed. It should be noted that during replacement, it was very easy to remove the chitin web-like material.
【0027】実施例3
キトサン粉末(新日本化学製,2%酢酸水溶液に0.2
%溶解した溶液粘度が250センチポイズ:B型回転粘
度計1000rpm)を3%酢酸水溶液に3重量%溶か
し,粘調で透明な溶液を得た。その溶液を1480メツ
シユステンレスネツトで濾過した後,加圧タンクに入れ
,ギヤーポンプにて計量送液した。さらに,0.07m
mφの微細なノズルから0.5%の苛性ソーダを含んだ
水溶液中に吐出して凝固した後,8m/min の速度
で捲取った。得られた繊維を十分に洗浄すると,単糸デ
ニール約1.5デニールのキトサン繊維が得られた。こ
の繊維を20mmの長さに切断した後,開繊カード機に
てキトサンウェブ状物を得た。これを圧迫してシート状
マツトにした。さらに滅菌した後に下腿潰瘍の治療に使
用した。Example 3 Chitosan powder (manufactured by Shin Nippon Chemical Co., Ltd., 0.2% in a 2% acetic acid aqueous solution)
% dissolved solution viscosity was 250 centipoise (B-type rotational viscometer 1000 rpm) was dissolved at 3% by weight in a 3% acetic acid aqueous solution to obtain a viscous and transparent solution. The solution was filtered through 1480 mesh stainless steel net, placed in a pressurized tank, and metered by a gear pump. Furthermore, 0.07m
After being discharged from a fine nozzle of mφ into an aqueous solution containing 0.5% caustic soda and solidified, it was wound up at a speed of 8 m/min. When the obtained fibers were thoroughly washed, chitosan fibers having a single yarn denier of about 1.5 denier were obtained. After cutting this fiber into a length of 20 mm, a chitosan web-like material was obtained using a fiber opening card machine. This was pressed into a sheet-like mat. After further sterilization, it was used to treat leg ulcers.
【0028】患者は68才の女性で,下腿部に静脈血行
不良のため潰瘍が発生したものであった。受傷後,約2
ヶ月間抗生物質の入った軟膏での治療が続けられていた
が,まったく改善のきざしがみえなかった。治療は,ま
ず,患部をポビドンヨード液で十分に洗浄した後,キト
サンウェブ状物マツトを軽く圧迫してあて,上層にガー
ゼをあてて粘着テープで固定した。キトサンウェブ状物
マツトの交換は,3日毎に行った。交換時には,ガーゼ
側に多量の滲出液の付着があった。12日目頃から良質
な肉芽が生成しはじめ,27日目で表皮形成が終了し,
完治した。The patient was a 68-year-old woman who had developed an ulcer in her lower leg due to poor venous blood circulation. After injury, approx. 2
Treatment with antibiotic ointment was continued for several months, but there was no sign of improvement at all. For treatment, first, the affected area was thoroughly washed with povidone-iodine solution, then a chitosan web mat was applied with light pressure, and the upper layer was covered with gauze and fixed with adhesive tape. The chitosan web mat was replaced every 3 days. At the time of replacement, there was a large amount of exudate on the gauze side. From around the 12th day, high-quality granulation begins to form, and on the 27th day, epidermis formation is completed.
Completely recovered.
【0029】[0029]
【発明の効果】本発明のキチンウェブ状物は,吸着材,
医療品等に使用され,特に創傷被覆保護材として使用さ
れると,患部への密着がよく,滲出液の除去効果に優れ
,肉芽生成,表皮形成にも優れているので,深い傷,例
えば,挫滅傷,褥瘡,下腿潰瘍等に使用し,高い治療効
果をあげることができる。[Effect of the invention] The chitin web-like material of the present invention can be used as an adsorbent,
When used in medical products, etc., especially as a wound dressing, it adheres well to the affected area, has an excellent exudate removal effect, and is also excellent in granulation and epidermis formation, so it can be used for deep wounds, e.g. It can be used for crush injuries, bedsores, leg ulcers, etc., and can be highly effective.
Claims (1)
キチンウェブ状物。1. A chitin web consisting of chitin fibers or fibrils.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3176247A JP3046099B2 (en) | 1991-06-19 | 1991-06-19 | Chitin or chitosan floc |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3176247A JP3046099B2 (en) | 1991-06-19 | 1991-06-19 | Chitin or chitosan floc |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04371161A true JPH04371161A (en) | 1992-12-24 |
JP3046099B2 JP3046099B2 (en) | 2000-05-29 |
Family
ID=16010225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3176247A Expired - Fee Related JP3046099B2 (en) | 1991-06-19 | 1991-06-19 | Chitin or chitosan floc |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3046099B2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09169653A (en) * | 1995-12-22 | 1997-06-30 | Unitika Ltd | Chitin-based hemostatic agent |
JPH09169654A (en) * | 1995-12-22 | 1997-06-30 | Unitika Ltd | Hemostatic agent |
JPH1075998A (en) * | 1996-09-05 | 1998-03-24 | Unitika Ltd | Cotton-like wound protective material |
US6402953B1 (en) | 1998-03-10 | 2002-06-11 | Rwe Nukem Gmbh | Adsorption means for radionuclides |
KR100509572B1 (en) * | 1998-07-28 | 2005-11-11 | 한상문 | Chitin artificial coating and chitin ointment for the treatment of defective skin |
JP2008532662A (en) * | 2005-03-17 | 2008-08-21 | 理源医▲療▼科技(上海)有限公司 | Method for producing antimicrobial wound dressing and use thereof |
JP2014237031A (en) * | 2007-02-19 | 2014-12-18 | マリン ポリマー テクノロジーズ,インコーポレーテッド | Hemostatic composition and therapeutic method |
US9642871B2 (en) | 2010-04-15 | 2017-05-09 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US10765698B2 (en) | 2011-04-15 | 2020-09-08 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-N-acetylglucosamine nanofibers |
-
1991
- 1991-06-19 JP JP3176247A patent/JP3046099B2/en not_active Expired - Fee Related
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09169653A (en) * | 1995-12-22 | 1997-06-30 | Unitika Ltd | Chitin-based hemostatic agent |
JPH09169654A (en) * | 1995-12-22 | 1997-06-30 | Unitika Ltd | Hemostatic agent |
JPH1075998A (en) * | 1996-09-05 | 1998-03-24 | Unitika Ltd | Cotton-like wound protective material |
US6402953B1 (en) | 1998-03-10 | 2002-06-11 | Rwe Nukem Gmbh | Adsorption means for radionuclides |
KR100509572B1 (en) * | 1998-07-28 | 2005-11-11 | 한상문 | Chitin artificial coating and chitin ointment for the treatment of defective skin |
JP2008532662A (en) * | 2005-03-17 | 2008-08-21 | 理源医▲療▼科技(上海)有限公司 | Method for producing antimicrobial wound dressing and use thereof |
JP2014237031A (en) * | 2007-02-19 | 2014-12-18 | マリン ポリマー テクノロジーズ,インコーポレーテッド | Hemostatic composition and therapeutic method |
US10383971B2 (en) | 2007-02-19 | 2019-08-20 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
US9642871B2 (en) | 2010-04-15 | 2017-05-09 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US10206938B2 (en) | 2010-04-15 | 2019-02-19 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US10561677B2 (en) | 2010-04-15 | 2020-02-18 | Marine Polymer Technologies, Inc. | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
US10765698B2 (en) | 2011-04-15 | 2020-09-08 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-N-acetylglucosamine nanofibers |
Also Published As
Publication number | Publication date |
---|---|
JP3046099B2 (en) | 2000-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6175053B1 (en) | Wound dressing material containing silk fibroin and sericin as main component and method for preparing same | |
EP0199531B1 (en) | Wound dressing | |
US20070104769A1 (en) | Bioabsorbable hemostatic gauze | |
JP3366994B2 (en) | Fiber | |
JP2579610B2 (en) | In vivo filler | |
Gupta et al. | Textile materials and structures for topical management of wounds | |
US4074713A (en) | Poly(N-acetyl-D-glucosamine) products | |
CA2397614A1 (en) | Honey based wound dressing | |
JP2008532662A (en) | Method for producing antimicrobial wound dressing and use thereof | |
JPH04235124A (en) | Gel having form of highly hydrated self- supporting film | |
JPH08505790A (en) | Trauma bandage | |
KR102413366B1 (en) | Wound dressing | |
WO2007056066A2 (en) | Bioabsorbable hemostatic gauze | |
JP3046099B2 (en) | Chitin or chitosan floc | |
EP0682534A1 (en) | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances | |
Gupta et al. | Textile materials and structures for wound care products | |
WO1992022285A1 (en) | Alginate wound dressings | |
JPH07102458A (en) | Chitin web material | |
JP2005102790A (en) | Wound covering material | |
JPH04178329A (en) | Antifungal material and antifungal wound covering protective material | |
RU2240140C2 (en) | Medicinal multilayer bandage and articles based on such bandage | |
JPH0566149B2 (en) | ||
JP4263871B2 (en) | Wound dressing and method for producing the same | |
JPH0442019B2 (en) | ||
JPH10151184A (en) | Functional wound protective material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080317 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090317 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100317 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110317 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |